Profile | GDS2987 / GI_24497546-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 49.9 | 70 |
GSM215244 | HMVEC_vehicle_rep2 | 25.8 | 53 |
GSM215253 | HMVEC_vehicle_rep3 | 30.9 | 64 |
GSM215254 | HMVEC_atorvastatin_rep1 | 52.2 | 69 |
GSM215282 | HMVEC_atorvastatin_rep3 | 56.7 | 69 |
GSM215344 | HMVEC_atorvastatin_rep2 | 52.7 | 69 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 36.1 | 56 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 38.2 | 58 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 62.3 | 67 |
GSM215294 | HMVEC_SLx2119_rep1 | 59.2 | 72 |
GSM215295 | HMVEC_SLx2119_rep2 | 51.8 | 66 |
GSM215296 | HMVEC_SLx2119_rep3 | 11 | 19 |
GSM215297 | PASMC_vehicle_rep1 | 25.2 | 37 |
GSM215298 | PASMC_vehicle_rep2 | 20 | 30 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 7.4 | 12 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 0.3 | 0 |
GSM215327 | PASMC_SLx2119_rep1 | 6.4 | 12 |
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 14.2 | 32 |
GSM215331 | Fibroblasts_vehicle_rep2 | 19.8 | 48 |
GSM215332 | Fibroblasts_vehicle_rep3 | 19.8 | 52 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 20.1 | 47 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 8 | 23 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 18.1 | 41 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 18 | 50 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 4.1 | 13 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 8.2 | 23 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 12.3 | 35 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 14.1 | 37 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 28.4 | 56 |